For years, cancer researchers have known: There are many more types of cancer than we thought. We can recognize tumors at their genetic profile – and find the individual treatment for everyone. For many patients even the chemotherapy can be dispensed.
Biotech companies have offered such genetic testing for some years, but the health insurance companies do not paybecause experts, officials and manufacturers argue about whether the new procedures are suitable – and what the test can detect at all. Moralizing at the expense of the patient? The story is about searching for clues among the actors. This multimedia storytelling was created as part of the Master Class “Future of Science Journalism” of the Robert Bosch Stiftung and the Reporter Forum, and published in the digital science magazine Substanz.